SUMC in the News (12/22/05)
SUMC in the News will be on hiatus until Tuesday, Jan. 3. Happy Holidays to all!
Print media coverage
San Jose Mercury News, 12/22/05
Children's health gains are at risk of reversal (registration required)
This piece on children's health is written by Paul Wise, Richard E. Behrman
Professor in Child Health and Society.
Modesto Bee, 12/22/05
Second heart beats 2-year mark
This article tells the story of a 9-year-old heart transplant survivor. Daniel
Bernstein, the Alfred Woodley Salter and Mabel Smith Salter Endowed Professor in
Pediatrics and chief of pediatric cardiology, is quoted here.
Newsday (New York), 12/22/05
Ex-LI athlete drives the lane for funds
This article profiles Erik Rausch, senior director of development of the Cancer
Center and the Stanford Institute for Stem Cell Biology and Regenerative
Medicine.
New Zealand Herald, 12/22/05
NZ patients test anti-cancer compound
Stanford is referenced in this article on a new anti-cancer drug being tested on
patients.
San Francisco Business Times, 12/19/05
Bayhill Therapeutics reports positive MS trial (registration required)
Bayhill Therapeutics Inc. reported good results Monday in an early stage
clinical trial on a drug for treating multiple sclerosis (MS). The article
mentions that the company's technology was developed in the laboratory of
Lawrence Steinman, professor of neurology and neurological sciences and of
pediatrics. The story also appears in the San Jose/Silicon Valley/Business
Journal.
Office of Communication